63539-501-14 |
63539-501 |
HUMAN PRESCRIPTION DRUG |
XELJANZ XR |
tofacitinib |
TABLET, EXTENDED RELEASE |
ORAL |
20160307 |
N/A |
NDA |
NDA208246 |
U.S. Pharmaceuticals |
TOFACITINIB CITRATE |
11 mg/1 |
14 TABLET, EXTENDED RELEASE in 1 BOTTLE (63539-501-14) |
63539-501-30 |
63539-501 |
HUMAN PRESCRIPTION DRUG |
XELJANZ XR |
tofacitinib |
TABLET, EXTENDED RELEASE |
ORAL |
20160307 |
N/A |
NDA |
NDA208246 |
U.S. Pharmaceuticals |
TOFACITINIB CITRATE |
11 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63539-501-30) |
63539-502-30 |
63539-502 |
HUMAN PRESCRIPTION DRUG |
XELJANZ XR |
tofacitinib |
TABLET, EXTENDED RELEASE |
ORAL |
20200121 |
N/A |
NDA |
NDA208246 |
U.S. Pharmaceuticals |
TOFACITINIB CITRATE |
22 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63539-502-30) |
0069-0501-30 |
0069-0501 |
HUMAN PRESCRIPTION DRUG |
XELJANZ XR |
tofacitinib |
TABLET, FILM COATED, EXTENDED RELEASE |
ORAL |
20160307 |
N/A |
NDA |
NDA208246 |
Pfizer Laboratories Div Pfizer Inc |
TOFACITINIB CITRATE |
11 mg/1 |
30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0501-30) |
0069-0502-30 |
0069-0502 |
HUMAN PRESCRIPTION DRUG |
XELJANZ XR |
tofacitinib |
TABLET, FILM COATED, EXTENDED RELEASE |
ORAL |
20200121 |
N/A |
NDA |
NDA208246 |
Pfizer Laboratories Div Pfizer Inc |
TOFACITINIB CITRATE |
22 mg/1 |
30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0502-30) |